You have 9 free searches left this month | for more free features.

ACTH gel

Showing 1 - 25 of 2,433

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Pittsburgh (ACTHAR gel)

Completed
  • Rheumatoid Arthritis
  • ACTHAR gel
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Sep 7, 2022

Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 13, 2023

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

Active, not recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Mar 29, 2022

Multiple Sclerosis Trial in Aurora, Philadelphia (ACTHAR Gel (ACTH), IV methylprednisolone (steroids))

Terminated
  • Multiple Sclerosis
  • ACTHAR Gel (ACTH)
  • IV methylprednisolone (steroids)
  • Aurora, Colorado
  • +1 more
Feb 24, 2022

Membranous Nephropathy Trial in New York (ACTHar)

Completed
  • Membranous Nephropathy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 20, 2022

Multiple Sclerosis Trial in New York (Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®))

Terminated
  • Multiple Sclerosis
  • Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)
  • New York, New York
    Weill Cornell Medicine
Dec 31, 2020

Transplant Glomerulopathy Trial in Birmingham, Baltimore (Acthar gel)

Terminated
  • Transplant Glomerulopathy
  • Acthar gel
  • Birmingham, Alabama
  • +1 more
Oct 3, 2022

Sarcoidosis Trial in Cleveland (Repository Corticotropin Injection)

Withdrawn
  • Sarcoidosis
  • Repository Corticotropin Injection
  • Cleveland, Ohio
    Cleveland Clinic Main Campus
Nov 19, 2020

CNS Sarcoidosis Trial in Baltimore (H.P. Acthar Gel)

Completed
  • CNS Sarcoidosis
  • H.P. Acthar Gel
  • Baltimore, Maryland
    University of Maryland, Baltimore
Mar 10, 2021

Multiple Sclerosis Trial in Buffalo (repository corticotropin injection, Saline)

Withdrawn
  • Multiple Sclerosis
  • repository corticotropin injection
  • Saline
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Dec 30, 2020

Renal Disease, Fibrillary Glomerulopathy Trial in Lawrenceville (Acthar 80 UNT/ML Injectable Solution, Oral Tab Tacrolimus)

Withdrawn
  • Renal Disease
  • Acthar 80 UNT/ML Injectable Solution
  • Oral Tab Tacrolimus
  • Lawrenceville, Georgia
    Georgia Nephrology Research Institute
Sep 20, 2022

Diabetic Nephropathy Trial in United States (Repository Corticotropin Injection, Placebo)

Completed
  • Diabetic Nephropathy
  • Repository Corticotropin Injection
  • Placebo
  • Roseville, California
  • +9 more
Oct 31, 2019

Nephrotic Syndrome in Children Trial in China (Adrenocorticotrophic Hormone, Steroid)

Recruiting
  • Nephrotic Syndrome in Children
  • Wuhan, Hubei, China
  • +7 more
Oct 8, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in United States (ACTH, Placebo)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Cullman, Alabama
  • +4 more
Aug 26, 2019

Progressive IgA Nephropathy, Proteinuria Trial in United States (ACTH (Acthar) Gel)

Completed
  • Progressive IgA Nephropathy
  • Proteinuria
  • ACTH (Acthar) Gel
  • Palo Alto, California
  • +3 more
Jun 4, 2019

Infant, Premature Birth Trial in Hatay (experimental group)

Not yet recruiting
  • Infant
  • Premature Birth
  • experimental group
  • Hatay, Antakya, Turkey
  • +1 more
Oct 4, 2023

Proteinuria, Idiopathic Membranous Nephropathy Trial in Worldwide (Repository Corticotropin Injection, Placebo)

Completed
  • Proteinuria
  • Idiopathic Membranous Nephropathy
  • Repository Corticotropin Injection
  • Placebo
  • Sacramento, California
  • +27 more
Nov 18, 2019

Uveitis Trial in Los Angeles, Palo Alto (ACTH gel)

Unknown status
  • Uveitis
  • ACTH gel
  • Los Angeles, California
  • +1 more
Sep 25, 2018

Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)

Recruiting
  • Cushing Syndrome
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023

FSGS, Renal Transplantation, Kidney Transplantation Trial in Chapel Hill (Acthar)

Withdrawn
  • FSGS
  • +2 more
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Aug 26, 2021

Combination Acthar Gel and Tacrolimus in Treatment of Steroid

Suspended
  • Nephrotic Syndrome
  • Acthar Gel and Tacrolimus
  • Chattanooga, Tennessee
    Nephronet
Feb 15, 2021

Adrenocorticotropic Hormone Stimulation During Adrenal Vein

Recruiting
  • Primary Aldosteronism
  • +2 more
    • Nanjing, Jiangsu, China
      Department of Endocrinology, Drum Tower Hospital affiliated to N
    Apr 11, 2023

    Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)

    Recruiting
    • Adrenocortical Carcinoma
    • Stanford, California
    • +5 more
    Jun 27, 2022

    Dry Eye Disease Trial in Nashville (Corticotropin 80Unit/Ml Repository Injection)

    Completed
    • Dry Eye Disease
    • Corticotropin 80Unit/Ml Repository Injection
    • Nashville, Tennessee
      Toyos Clinic
    Jan 8, 2021

    Gorlin Syndrome Trial (Patidegib Topical Gel, Vehicle Gel)

    Not yet recruiting
    • Gorlin Syndrome
    • Patidegib Topical Gel
    • Vehicle Gel
    • (no location specified)
    Sep 15, 2023